Objectives: Study of the hemodynamic profile and oxygenation variables in s
evere malaria to determine whether they are identical to those observed in
severe bacterial infections.
Design and setting: Prospective study in an intensive care unit of a West A
frican hospital.
Patients and participants: Two groups of adult patients hospitalized for se
vere malaria according to WHO criteria, a control group (n = 13) with syste
mic vascular resistance of 800 dyne s(-1) cm(-5) or higher and a hyperkinet
ic group (n = 16) with a level lower than 800 dyne s(-1) cm(-5). Twenty-nin
e patients participated in this study (19 semi-immune, 10 nonimmune),
Interventions: Before hemodynamic study a loading dose of quinine formiate
was administered: 20 mg/kg intravenously for 4 h. Artificial ventilation wa
s used in the case of persistent hypoxemia.
Measurements and results: The hemodynamic study with Swan-Ganz catheter was
performed after filling with 1000 ml lactated Ringer's solution. From a cl
inical and a biological standpoint there was no difference between the two
groups except for creatine phosphokinase, which was significantly higher in
the hyperkinetic group: 2404 +/- 3654 vs. 1898 +/- 1828 IU/l. Hemodynamic
and oxygenation variables showed a significant difference in cardiac index
(6.1 +/- 1.2 vs. 3.9 +/- 1.2 l min(-1) m(-2)), systemic vascular resistance
(536 +/- 143 vs. 1098 +/- 170 dyne s(-1) cm(-5)), oxygen delivery (645 +/-
163 vs. 482 +/- 186 ml min(-1) m(-2)), and oxygen extraction (23 +/- 9% vs
. 34 +/- 14%). Oxygen extraction was negatively correlated with oxygen deli
very in the control group but not in the hyperkinetic group. Eight of 10 no
nimmune patients (80 %) were in the hyperkinetic group versus 8 of 19 semi-
immune patients (42 %; p < 0.05). Nine patients in the hyperkinetic group (
69 %) and seven of the control group (46%) died (NS).
Conclusions: In contrast to severe bacterial infections, severe malaria doe
s not always induce hyperkinetic-type hemodynamic changes. Such changes are
observed mostly in nonimmune subjects.